Explore how IMCD's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 5.2% p.a. on average ...
Irvine-based J+R Group recently sold the 143,269-square-foot mid-rise office tower in Irvine for $37.6 million to Pacific Tree Capital in Dana Point. The building, named 2525 Main St. after its ...
Hosted on MSN1mon
Terminally ill man 'cured' of immune illness by AI technologyThe patient, who is remaining anonymous, has idiopathic multicentric Castleman's disease (iMCD), which has an especially poor survival rate and few treatment options. But an AI tool searched ...
Kepler Capital analyst Matthias Maenhaut maintained a Buy rating on IMCD N.V. (0QVU – Research Report) on March 10 and set a price target of ...
IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announced it has committed to the Science Based Target initiative ...
A press release from Penn Medicine News explained that iMCD is a cytokine storm disorder “in which too many inflammatory cytokines … are released and can damage the body’s tissues and organs.” ...
In a report released on March 5, Matthias Maenhaut from Kepler Capital maintained a Buy rating on IMCD N.V. (0QVU – Research Report), with a ...
SINGAPORE: IMCD Group, a leading speciality chemicals and food ingredients company, has acquired the pharmaceutical ingredients business of Maxwell Pharma Sdn Bhd, a family-owned Malaysian company.
IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its full year 2024 results. HIGHLIGHTS• Gross profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results